| Gene ID | 3557 |
| Symbol | IL1RN |
| Synonymous | DIRA|ICIL-1RA|IL-1RN|IL-1ra|IL-1ra3|IL1F3|IL1RA|IRAP|MVCD4 |
| Full name | interleukin 1 receptor antagonist |
| Gene description | IL1 inhibitor|IL1RN (IL1F3)|interleukin-1 receptor antagonist protein|intracellular IL-1 receptor antagonist type II|intracellular interleukin-1 receptor antagonist (icIL-1ra)|type II interleukin-1 receptor antagonist |
| Cytoband | 2q14.2 |
| Gene type | protein-coding |
| Synonymous | MIM:147679; HGNC:HGNC:6000; Ensembl:ENSG00000136689; HPRD:00978; Vega:OTTHUMG00000131341 |
Pathways and Diseases | Detail |
|---|---|
Pathway | Signaling in Immune system;Reactome;REACT:6900 |
Pathway | Interleukin-1 signaling;PID Reactome;500490 |
Pathway | IL1-mediated signaling events;PID Curated;200075 |
Pathway | signal transduction through il1r;PID BioCarta;100132 |
Disease | atopy;GAD |
Disease | Premature birth;FunDO |
Disease | gastric carcinoma;GAD |
Disease | Purpura, Thrombocytopenic, Idiopathic;FunDO |
Disease | resistance to liver graft rejection to steroid therapy;GAD |
Disease | IMMUNE;GAD |
Disease | Multiple myeloma;FunDO |
Disease | meningococcal disease;GAD |
Disease | Alopecia;FunDO |
Disease | Polycystic ovary syndrome;FunDO |
Disease | Peptic ulcer;FunDO |
Disease | Severe sepsis;GAD |
Disease | Colon cancer;FunDO |
Disease | Cervical cancer;FunDO |
Disease | Prostatic hypertrophy, Benign;FunDO |
Disease | cirrhosis, biliary primary;GAD |
Disease | Bronchopulmonary dysplasia;FunDO |
Disease | Protein quantitative trait loci;NHGRI |
Disease | early postmenopausal bone loss at the spine.;GAD |
Disease | Malaria;FunDO |
Disease | respiratory syncytial virus bronchiolitis;GAD |
Disease | Hypertension;FunDO |
Disease | multiple sclerosis;GAD |
Disease | Enteritis;FunDO |
Disease | coronary atherosclerosis;GAD |
Disease | vulvar vestibulitis syndrome;GAD |
Disease | Atherosclerosis;FunDO |
Disease | Severe sepsis/nonsurvival;GAD |
Disease | Ischemia;FunDO |
Disease | Alcoholic liver disease;FunDO |
Disease | Lung cancer;FunDO |
Disease | sepsis;GAD |
Disease | ankylosing spondylitis;GAD |
Disease | nephropathy;GAD |
Disease | rhinitis;GAD |
Disease | Dermatitis;FunDO |
Disease | vulvar cancer;GAD |
Disease | silicosis;GAD |
Disease | Histiocytosis;FunDO |
Disease | alopecia areata;GAD |
Disease | Systemic infection;FunDO |
Disease | Drug abuse;FunDO |
Disease | Gastritis;FunDO |
Disease | Gastric cancer risk after H. pylori infection;OMIM |
Disease | Solid tumor;FunDO |
Disease | malaria;GAD |
Disease | acute pancreatitis;GAD |
Disease | Graft-versus-host disease;KEGG DISEASE;H00084 |
Disease | Abortion;FunDO |
Disease | Early Onset Periodontitis;GAD |
Disease | Ovarian cancer;FunDO |
Disease | Heart disease;FunDO |
Disease | Bacterial vaginosis;FunDO |
Disease | Allergies and autoimmune diseases;KEGG DISEASE |
Disease | Periodontal disease;FunDO |
Disease | ulcerative colitis;GAD |
Disease | Lupus erythematosus;FunDO |
Disease | endometriosis;GAD |
Disease | rate of decline in lung function in smokers;GAD |
Disease | Asthma;FunDO |
Disease | Type 2 Diabetes related glucose homeostasis traits;GAD |
Disease | renal involvement and renal sequelae;GAD |
Disease | Prostate cancer;FunDO |
Disease | psoriasis;GAD |
Disease | protein quantitative trait loci;GAD |
Disease | METABOLIC;GAD |
Disease | alcoholism;GAD |
Disease | rheumatoid arthritis;GAD |
Disease | gastric cancer;GAD |
Disease | CARDIOVASCULAR;GAD |
Disease | Schizophrenia;FunDO |
Disease | Labor, Premature;FunDO |
Disease | Brucellosis;FunDO |
Disease | Interleukin 1 receptor antagonist deficiency;OMIM |
Disease | primary open-angle glaucoma;GAD |
Disease | Chronic obstructive airway disease;FunDO |
Disease | REPRODUCTION;GAD |
Disease | Attention deficit hyperactivity disorder;FunDO |
Disease | Malnutrition;FunDO |
Disease | IgA nephropathy;GAD |
Disease | Immune system diseases;KEGG DISEASE |
Disease | Obesity;FunDO |
Disease | Microvascular complications of diabetes, susceptibility to, 4;OMIM |
Disease | stomach cancer;GAD |
Disease | Alzheimer's disease;GAD |
Disease | Graves disease;GAD |
Disease | Hepatitis B, Chronic;GAD |
Disease | Stomach cancer;FunDO |
Disease | Chronic simple glaucoma;FunDO |
Disease | Cystic fibrosis;FunDO |
Disease | VISION;GAD |
Disease | Systemic scleroderma;FunDO |
Disease | Ulcerative colitis;FunDO |
Disease | Asthma;GAD |
Disease | periodontitis;GAD |
Disease | Stroke;FunDO |
Disease | thromboembolism, venous;GAD |
Disease | Autoimmune disease;FunDO |
Disease | Encephalitis;FunDO |
Disease | CHEMDEPENDENCY;GAD |
Disease | vulvar carcinogenesis;GAD |
Disease | lung cancer;GAD |
Disease | CANCER;GAD |
Disease | Cerebrovascular disorder;FunDO |
Disease | Kidney failure;FunDO |
Disease | Endometriosis;FunDO |
Disease | NEUROLOGICAL;GAD |
Disease | enhanced IL-1beta production;GAD |
Disease | INFECTION;GAD |
Disease | Hodgkin's disease;FunDO |
Disease | arthritis lymphopenia nephritis, lupus;GAD |
Disease | Cushing syndrome;FunDO |
Disease | RENAL;GAD |
Sequence Information | |
|---|---|
Nucleotide Sequence | >3557 : length: 2411 AGAGACAGAGGCTCAACTAATGAAATGATTTGTTCAAGGTCACACGGGTGGCACAAGGCAAGTGGCAGAGGTTGAATTTAGACCCATTCCTGTCCAAATGCTGAGTTTATGTCATCGTCC CGAGACCATAACTTTAAAGATGTAAGATAGTGGGAAAAGAGTTGATTTCAAAGCACCTCTCAGAAGGACTCACTTTACATCAGGGGTCAGCAGACTCAGGCCAAATCCGGTCCATTCCCC GCTTTTGCAAAGAAAGTTGTAGTGGAACACAGCTAGGCTTATTGATTTATGGATTGCCAACGTCCTTTTGTGAAACAGACAGCTGAGCTGAGTAATCGTGGCGCACAAAACCTAAAATAT TTACTATCTCGTCCTTTACAGAATGTTTGCCAATCTATGGTCCGGAGTCCAAGGCTGTCCATTTTTCAAAGAACACAAAGTGACATGAGACTGTCCCATGTGCAGGGAGCCCTATCATTT TATTATGAAAAAACGGCCTTTCTGCTCAAATCTGTTTTTTAAAAAGTCAACAAACAGACTCTGGGTACCTGTCAGGAACAGTAGGGAGTTTGGTTTCCATTGTGCTCTTCTTCCCAGGAA CTCAATGAAGGGGAAATAGAAATCTTAATTTTGGGGAAATTGCACAGGGGAAAAAGGGGAGGGAATCAGTTACAACACTCCATTGCGACACTTAGTGGGGTTGAAAGTGACAACAGCAAG GGTTTCTCTTTTTGGAAATGCGAGGAGGGTATTTCCGCTTCTCGCAGTGGGGCAGGGTGGCAGACGCCTAGCTTGGAGACGATCTGCCGACCCTCTGGGAGAAAATCCAGCAAGATGCAA GCCTTCAGAATCTGGGATGTTAACCAGAAGACCTTCTATCTGAGGAACAACCAACTAGTTGCTGGATACTTGCAAGGACCAAATGTCAATTTAGAAGAAAAGATAGATGTGGTACCCATT GAGCCTCATGCTCTGTTCTTGGGAATCCATGGAGGGAAGATGTGCCTGTCCTGTGTCAAGTCTGGTGATGAGACCAGACTCCAGCTGGAGGCAGTTAACATCACTGACCTGAGCGAGAAC AGAAAGCAGGACAAGCGCTTCGCCTTCATCCGCTCAGACAGTGGCCCCACCACCAGTTTTGAGTCTGCCGCCTGCCCCGGTTGGTTCCTCTGCACAGCGATGGAAGCTGACCAGCCCGTC AGCCTCACCAATATGCCTGACGAAGGCGTCATGGTCACCAAATTCTACTTCCAGGAGGACGAGTAGTACTGCCCAGGCCTGCCTGTTCCCATTCTTGCATGGCAAGGACTGCAGGGACTG CCAGTCCCCCTGCCCCAGGGCTCCCGGCTATGGGGGCACTGAGGACCAGCCATTGAGGGGTGGACCCTCAGAAGGCGTCACAACAACCTGGTCACAGGACTCTGCCTCCTCTTCAACTGA CCAGCCTCCATGCTGCCTCCAGAATGGTCTTTCTAATGTGTGAATCAGAGCACAGCAGCCCCTGCACAAAGCCCTTCCATGTCGCCTCTGCATTCAGGATCAAACCCCGACCACCTGCCC AACCTGCTCTCCTCTTGCCACTGCCTCTTCCTCCCTCATTCCACCTTCCCATGCCCTGGATCCATCAGGCCACTTGATGACCCCCAACCAAGTGGCTCCCACACCCTGTTTTACAAAAAA GAAAAGACCAGTCCATGAGGGAGGTTTTTAAGGGTTTGTGGAAAATGAAAATTAGGATTTCATGATTTTTTTTTTTCAGTCCCCGTGAAGGAGAGCCCTTCATTTGGAGATTATGTTCTT TCGGGGAGAGGCTGAGGACTTAAAATATTCCTGCATTTGTGAAATGATGGTGAAAGTAAGTGGTAGCTTTTCCCTTCTTTTTCTTCTTTTTTTGTGATGTCCCAACTTGTAAAAATTAAA AGTTATGGTACTATGTTAGCCCCATAATTTTTTTTTTCCTTTTAAAACACTTCCATAATCTGGACTCCTCTGTCCAGGCACTGCTGCCCAGCCTCCAAGCTCCATCTCCACTCCAGATTT TTTACAGCTGCCTGCAGTACTTTACCTCCTATCAGAAGTTTCTCAGCTCCCAAGGCTCTGAGCAAATGTGGCTCCTGGGGGTTCTTTCTTCCTCTGCTGAAGGAATAAATTGCTCCTTGA CATTGTAGAGCTTCTGGCACTTGGAGACTTGTATGAAAGATGGCTGTGCCTCTGCCTGTCTCCCCCACCGGGCTGGGAGCTCTGCAGAGCAGGAAACATGACTCGTATATGTCTCAGGTC CCTGCAGGGCCAAGCACCTAGCCTCGCTCTTGGCAGGTACTCAGCGAATGAATGCTGTATATGTTGGGTGCAAAGTTCCCTACTTCCTGTGACTTCAGCTCTGTTTTACAATAAAATCTT GAAAATGCCTA |
Protein Sequence | >3557 : length: 180 MALADLYEEGGGGGGEGEDNADSKETICRPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENR KQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE |